WeVote

Bill

Bill

SB 271

AN ACT RELATING TO INSURANCE -- BENEFIT DETERMINATION AND UTILIZATION REVIEW ACT

2025 Regular Session Introduced by Pete Appollonio and 7 co-sponsors

Rhode Island bill modifies insurance utilization review procedures to establish new standards for medical treatment approval timelines and patient appeal rights in coverage decisions.

05/14/2025 Referred to House Health & Human Services
0
WeVote Research Nonpartisan
Bill Summary · SB 271

Legislative bill overview

SB 271 amends Rhode Island's insurance benefit determination and utilization review processes to establish or modify requirements for how insurers evaluate and approve medical treatments. The bill specifies procedural standards for medical necessity reviews and appeals, affecting both insurers' decision-making timelines and patients' ability to challenge coverage denials.

Why is this important

Utilization review decisions directly impact whether patients can access prescribed treatments without delay or financial hardship. These procedural changes affect millions of Rhode Island insurance enrollees by potentially shortening approval times, clarifying appeal rights, or changing evidence standards—ultimately determining healthcare access and out-of-pocket costs for covered services.

Potential points of contention

  • Insurance industry costs: Faster approval timelines or stricter approval standards may increase insurer operational expenses, potentially leading to higher premiums or reduced profit margins
  • Medical evidence standards: Disagreement over what constitutes adequate clinical evidence for approval decisions, particularly regarding newer treatments or off-label uses
  • Appeal process complexity: Balancing robust patient protections with administrative feasibility—more stringent appeals could overwhelm insurers while insufficient protections leave patients vulnerable to arbitrary denials

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.